London, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a pipeline of therapeutics designed to transform large protein degraders into small molecules for targeted protein degradation. Kesmalea Therapeutics is based in London, United Kingdom and was founded in 2020. Its last known valuation is $39 million. It has raised $37.8 million.
Last price · $/share
—
Implied valuation
$39.0M
Total raised
$37.8M
Last round
—
Team — not yet on record
No current team members for Kesmalea Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kesmalea Therapeutics with a free account
·Watch Kesmalea Therapeutics: the Monday email on marks, rounds and moves
